McKesson Corporation vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? McKesson Corporation trades at $937.1 (market cap $108.46B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.77 (market cap $24.42B). The key difference: McKesson Corporation is far larger — about 4.4× Direxion Daily Semiconductor Bull 3X Shares's market cap, and McKesson Corporation pays a 0.4% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| MCK | SOXL | |
|---|---|---|
Market Cap | $108.46B | $24.42B |
Volume | 712,607 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $995.69 | $300.77 |
52-Week Low | $725.17 | $30.81 |
Typical Hold Time | 74 Days | 15 Days |
Enterprise Value | $115.00B | — |
Dividend Yield | 0.4% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $938.84, up 3.13% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
The outlook is positive with 81% analyst buy ratings and a $956.43 consensus price target. Key risks include margin pressure from drug pricing policies and high current liabilities of $61.60B. The stock's valuation at 24.95x P/E appears reasonable given earnings growth projections, but investors should monitor debt levels and regulatory developments in healthcare distribution.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $139.76, down 12.05% with a bearish technical signal. The fund faces volatility from its 3x leverage on semiconductor stocks, which have shown mixed performance amid strong AI demand but regulatory and market risks. Recent news highlights sector rebounds and institutional selling, while technical indicators show neutral oscillators and key support at $134.
Outlook is cautious due to leverage amplifying sector swings; opportunities exist if semiconductor fundamentals hold, but risks include tariff concerns and overcrowded trades. Investors should weigh high volatility against AI-driven growth potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →